netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Capecitabine found 15 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Capecitabine Malignant disease and immunosuppression - Antimetabolites - 08.01.03
  Cytotoxic Drug Gemcitabine Malignant disease and immunosuppression - Antimetabolites - 08.01.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (Jan 2014): Capecitabine: risk of severe skin reactions - discontinue treatment (08.01.03)
link in drug section MHRA Drug Safety Update (Oct 2020): 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity (08.01.03)
link in drug section MHRA Drug Safety Update (Oct 2020): 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity (08.01.03)
link in drug section MHRA Drug Safety Update (Oct 2020): 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity (08.01.03)
link in drug section MHRA Drug Safety Update (Oct 2020): 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity (08.01.03)
link in drug section NHS England SSC1959 - Clinical Commissioning Policy: Gemcitabine and capecitabine following surgery for pancreatic cancer (all ages) (08.01.03)
link in drug section NHS England SSC1959 - Clinical Commissioning Policy: Gemcitabine and capecitabine following surgery for pancreatic cancer (all ages) (08.01.03)
link in drug section NICE TA100: Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer (08.01.05)
link in drug section NICE TA100: Colon cancer (adjuvant) - capecitabine and oxaliplatin (08.01.03)
link in drug section NICE TA191: Gastric cancer (advanced) - capecitabine (08.01.03)
link in drug section NICE TA61: Colorectal cancer - capecitabine and tegafur uracil (08.01.03)
link in drug section NICE TA61: Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer (08.01.03)
link in drug section NICE TA786: Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies (08.01.05)


 
netFormulary